Credit: Georgia Tech / Tony Kim
High-throughput production of protein nanoparticles, illustrated here, allows for highly reproducible experiments and also the productive standardized assembly of nanoparticles that may prove to be good drug candidates for clinical trials to treat atherosclerosis.